“In the beginning, it was the other patients at the photopheresis center that kept me coming. Since it took a while [to start seeing results], I wanted to stop. But the others kept with me and encouraged me to stay. So I did—and I’m glad I did. Photopheresis has helped me tremendously.” *
Many people live with CTCL for many years. And many of them have been helped by THERAKOS™ Photopheresis. So it’s important to know that you’re not alone. Sometimes it helps to hear their voices, to understand that they once faced the same feelings, the same anxieties.
“The tormenting part about CTCL, for me, was the itching. And now [with photopheresis], it’s almost gone, almost nil. I’ve been getting treatments for about four years and...maybe once in a while I’m a little tired the day after, but that’s all.”*
* Not everyone responds to THERAKOS™ Photopheresis therapy and individual responses may vary
Questions you can ask
Specially designed for medical professionals to use in their practice.
See top Opinion Leaders address FAQs about THERAKOS™ Photopheresis
Indications
Methoxsalen Sterile Solution is indicated for extracorporeal administration with the THERAKOS™ UVAR XTS® or THERAKOS™ CELLEX® Photopheresis System in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment.
Methoxsalen is not appropriate for patients who have had a reaction to psoralen compounds, patients who have had a light sensitive disease, or patients with an absence of one or both lenses of the eye.
THERAKOS™ Photopheresis is not appropriate for patients who cannot tolerate blood volume changes or patients with blood clotting disorders. See Important Safety Information for additional details.
